Single Dose

Related by string. * sin gle . sin gles . SINGLE . Singles . SINGLES . singles : Grand Slam singles . chart topping singles . Single Sign . Single Touch . Single Ladies Put . Single Payer / DO Se . Doses . DOSE . DOSES . doses . dose : mg kg dose . tolerated dose MTD . label dose escalation . dose escalation study . multiple ascending dose . priming doses * single dose vials . single dose nevirapine *

Related by context. All words. (Click for frequent words.) 83 Prolongs Survival 82 Phase IIb Trial 81 Phase III Clinical Trial 81 Meets Primary Endpoint 81 Improves Survival 81 NDA Submission 81 Phase 2b Clinical Trial 80 Phase 2b Trial 80 Improves Outcomes 80 Mylan Receives Approval 80 Submits NDA 80 Study Evaluating 79 Receives Orphan Drug Designation 79 Investigational Agent 79 Previously Treated 79 Adjunctive Therapy 79 Well Tolerated 79 Appears Safe 79 FDA Approvals 79 Pooled Analysis 79 Gout Drug 79 Drug Candidate 79 Generic Version 79 Complicated Skin 78 Completes Enrollment 78 Phase 2a Trial 78 Completes Patient Enrollment 78 Patient Enrollment 78 Reduces Risk 78 Epilepsy Drug 78 Adjuvant Treatment 78 Study Showed 78 Significantly Reduced 78 Patients Receiving 78 Clinical Trial Results 78 Vaginal Gel 78 FDA Okays 78 Investigational Compound 78 Rotavirus Vaccine 78 Phase III Trial 78 Demonstrates Significant 78 Generic Versions 78 Protease Inhibitor 78 Fungal Infections 77 Novel Oral 77 Phase 2a Clinical Trial 77 Transdermal Patch 77 Elderly Patients 77 Clinical Trial Evaluating 77 Cholesterol Lowering Drug 77 Expanded Indication 77 IND Application 77 Oral Fingolimod 77 Osteoporosis Drug 77 First Patient Dosed 77 Unfractionated Heparin 77 Blood Pressure Drug 77 Pediatric Patients 77 Combination Treatment 77 Demonstrates Efficacy 77 Mg Uk 77 Phase IIb Clinical Trial 77 Inhaled Corticosteroids 77 Advanced Melanoma 77 Demonstrated Significant 77 FDA Clears 77 Metastatic Melanoma 77 Treatment Naïve 77 Lupus Drug 77 PRN FDA Approves 77 See CLINICAL PHARMACOLOGY 77 Receives Approvable Letter 77 Shows Promising 77 Announces Tentative Approval 77 Hypertensive Patients 77 Demonstrate Significant 77 Extended Release 77 Phase IIa Clinical Trial 77 Treated Patients 77 Patients Treated With 76 Hormone Refractory Prostate Cancer 76 Pulmonary Arterial Hypertension 76 Prostate Cancer Vaccine 76 Investigational Treatment 76 Antitumor Activity 76 Patients Suffering 76 Demonstrates Positive 76 Proven Effective 76 Proves Effective 76 Dose Escalation 76 Initiates Clinical Trial 76 Significantly Reduces 76 Showed Significant 76 Files IND 76 Patients Treated 76 Knee Osteoarthritis 76 FDA Accepts 76 Peginterferon Alfa 2a 76 Survival Benefit 76 Phase III Trials 76 Low Dose 76 Advanced Prostate Cancer 76 Previously Untreated 76 Granted Orphan Drug 76 Is Well Tolerated 76 Novel Antibiotic 76 Combination Therapy 76 Successfully Completes Phase 76 Phase 2b Study 76 Long Term Efficacy 76 Monotherapy 76 Pivotal Study 76 Fracture Risk 76 Recombinant Human 76 Statin Therapy 76 Pivotal Phase III 76 Chronic Hepatitis B 76 Effectively Treats 76 Demonstrates Potent 76 Hepatitis C Genotype 76 Reduces Pain 76 Treatment Naive Patients 76 Rheumatoid Arthritis Patients 76 Seasonal Influenza Vaccine 76 Versus Placebo 76 Newly Diagnosed Multiple Myeloma 76 Prophylactic Treatment 76 Maleate 76 Treating Chronic 76 FDA APPROVES 76 Premature Infants 76 Melphalan 76 Inhalation Aerosol 76 Shingles Vaccine 76 Phase 1b Clinical Trial 76 Hepatitis C Patients 76 Glatiramer Acetate 76 Kidney Transplant Patients 76 Mg Usa 76 Controlled Trial 76 Rheumatoid Arthritis Drug 76 Myeloma Patients 75 Initiates Enrollment 75 Placebo Controlled Trial 75 Relapsing Multiple Sclerosis 75 Non Responders 75 Shows Promise Against 75 Controlled Study 75 Receives Positive Opinion 75 Present Preclinical Data 75 Migraine Drug 75 Antiviral Activity 75 Preclinical Data 75 Peginterferon 75 HER2 Positive 75 HCV Protease Inhibitor 75 Initiate Phase III 75 Improve Survival 75 II Clinical Trial 75 Severe Sepsis 75 Plus Ribavirin 75 Vaccine Adjuvant 75 Confirmatory Phase 75 Breast Cancer Recurrence 75 Drug Combo 75 Significantly Improved 75 Trial Evaluating 75 Slow Progression 75 Initiates Clinical 75 Testosterone Gel 75 Potentially Fatal 75 Anti Tumor Activity 75 Resistant Hypertension 75 Randomized Double Blind 75 Inhaled Nitric Oxide 75 Drug Fails 75 Heart Failure Patients 75 Secondary Hyperparathyroidism 75 Fixed Dose 75 Significantly Improves 75 Premenopausal Women 75 Hsp# Inhibitor 75 Antiviral Drugs 75 Chronic Hepatitis C 75 Sustained Release 75 Osteoporosis Treatment 75 Efficacy Trial 75 Monoclonal Antibody 75 Pivotal Phase 75 Infected Patients 75 Hydrochlorothiazide Tablets 75 Statistically Significant 75 Posaconazole 74 Initiates Phase III 74 Haemophilus b Conjugate 74 Renal Cell Carcinoma 74 Shows Efficacy 74 Effective Than 74 Combo Therapy 74 Dose Ranging Study 74 Antitumor 74 Ondansetron Injection USP 74 Blood Thinner 74 Pharmacokinetic Study 74 Nicotine Vaccine 74 Topical Treatment 74 Adjuvant Chemotherapy 74 Milestone Payment 74 Teva Provides Update 74 Metastatic Prostate Cancer 74 Initiates Clinical Trials 74 Fondaparinux 74 Anti Tumor 74 Naive Patients 74 Beta Blocker 74 FDA Approves 74 Kidney Function 74 Tablet Formulation 74 Plaque Psoriasis 74 Double Blind Placebo 74 Drug Shows Promise 74 IND Filing 74 Oral Insulin 74 ACE Inhibitors 74 Presents Positive 74 Initiate Phase 74 Patients Undergoing 74 Disease Modifying 74 Generic Version Of 74 Tezampanel 74 Presents Preclinical Data 74 Fewer Side Effects 74 Initiate Clinical Trial 74 Polymerase Inhibitor 74 Study Demonstrates 74 Increased Mortality 74 Prostate Cancer Patients 74 Demonstrates Potential 74 Osteoporosis Drugs 74 Disease Progression 74 Pivotal Trial 74 Acetate Rectal Suppositories 74 Sevelamer 74 Achieves Primary Endpoint 74 Postmenopausal Women 74 Therapy Improves 74 Antiplatelet 74 Metformin HCl 74 Invasive Fungal Infections 74 Lowers Risk 74 Launches Generic Version 74 Initiates Phase II 74 Immune Responses 74 Investigational Drug 74 Pneumococcal Vaccine 74 abacavir sulfate lamivudine 74 Chronic Sinusitis 74 Combination REOLYSIN R 74 Liver Failure 74 Arthritis Drug 74 Bosutinib 74 Refractory Hodgkin Lymphoma 74 Smallpox Vaccine 74 Rotavirus Vaccines 74 Diabetic Neuropathy 74 Cholesterol Lowering 74 Diabetic Patients 74 Advanced Colorectal Cancer 74 Clinical Study Shows 74 Psoriasis Drug 74 Lung Cancer Survival 74 Immunosuppressant 74 Desvenlafaxine Succinate 74 Demonstrates Sustained 74 First Patient Enrolled 73 Enlarged Prostate 73 Improved Survival 73 Schizophrenia Drug 73 Benign Prostatic Hyperplasia 73 Treatment Reduces 73 Tiotropium 73 Renal Impairment 73 Epilepsy Drugs 73 Anti Inflammatory Drug 73 Antifungal 73 Gene Variant 73 Submits Biologics License Application 73 Androgen Deprivation Therapy 73 Treatment Resistant 73 Fast Track Status 73 Receives Milestone Payment 73 Anticancer Activity 73 Receptor Agonist 73 Symptom Relief 73 Hepatitis B Vaccine 73 Overactive Bladder 73 methylnaltrexone bromide 73 Fluticasone 73 Asthma Treatment 73 Lung Cancer Trial 73 Suppositories 73 Phospholipase A2 73 Parathyroid Hormone 73 Data Suggest 73 Artery Disease 73 Sapacitabine 73 Pivotal Trials 73 Inflammatory Markers 73 Oral Calcitonin 73 Beneficial Effects 73 Statin Drugs 73 Interferon Beta 73 Intranasal 73 Levels Linked 73 BioElectronics Announces 73 Lowers Blood Pressure 73 Commonly Prescribed 73 Advanced Renal Cell 73 Postmenopausal Osteoporosis 73 Lung Cancer Drug 73 Nebulized 73 Phase III Clinical Trials 73 JAK Inhibitor 73 REPRONEX R menotropins 73 Cholesterol Drugs 73 Orally Active 73 Lung Cancer Patients 73 Critically Ill Patients 73 Pre Cancerous 73 Increases Risk 73 Neoadjuvant Chemotherapy 73 Initiates Phase 73 Anti Inflammatory 73 Relapsed Multiple Myeloma 73 Investigational Oral 73 Double Blind Randomized 73 Shows Promise 73 Dosing Regimen 73 Hormone Receptor Positive 73 Drug Resistant 73 Tumor Targeting 73 Higher Doses 73 Metastatic Colorectal Cancer 73 Anticoagulant 73 Migraine Pain 73 FDA Panel Recommends 73 Tipranavir 73 Zorbtive TM 73 Announces FDA Clearance 73 Clinically Proven 73 Novel Inhibitor 73 Develop Novel 73 brand levalbuterol HCl Inhalation 73 Treatment Experienced 73 Autologous Stem Cell Transplantation 73 Diabetic Neuropathic Pain 73 PDUFA Date 73 receiving INTRON 73 Efficacious 73 Cocaine Addiction 73 Bepreve TM 73 Schizophrenia Treatment 73 Cholesterol Drug 73 AnaSpec Introduces 73 Virus Linked 73 Pain Medications 73 Pivotal Clinical Trial 72 Nucleoside 72 Predict Risk 72 Epoetin Alfa 72 Receives Tentative Approval 72 Earns Milestone Payment 72 Receives FDA Clearance 72 PROCTOCORT R 72 Colorectal Cancer Patients 72 Obese Patients 72 Randomized Clinical Trials 72 TNF Tumor Necrosis Factor 72 Coadministration 72 #mg/#mg 72 Blood Clot Risk 72 Serious Side Effects 72 Immunomodulatory 72 Partial Onset Seizures 72 Urinary Tract Infections 72 Oral Mucositis 72 Multiple Myeloma Patients 72 Estrogen Therapy 72 vapreotide acetate 72 Novel Compound 72 brand ciclesonide HFA 72 Positive Opinion 72 Therapy Reduces 72 JAK2 Inhibitor 72 Prospective Randomized 72 Humanized Anti 72 Attenuates 72 Treatment Regimen 72 Liver Damage 72 Aztreonam Lysine 72 Crit Rev 72 Slows Progression 72 Oral Formulation 72 CYP#A# CYP#D# 72 Commences Phase 72 Reduced Risk 72 FDA Warns Against 72 Clinical Trial Data 72 Kinase Inhibitor 72 Anemia Drug 72 Shown Effective 72 FDA Approves Drug 72 Phase III Pivotal Trial 72 Anti Nausea 72 Medoxomil 72 Fluticasone Propionate 72 minocycline HCl USP 72 Cardiovascular Events 72 topical gel formulation 72 Hospital Acquired Pneumonia 72 Receives Complete Response 72 Tigecycline 72 Receptor Antagonist 72 Relapsed Refractory 72 Tumor Growth 72 Hemodialysis Patients 72 Oral Solution 72 Benazepril 72 Vitrasert R 72 Patients Enrolled 72 Phase III Pivotal 72 Therapeutic Efficacy 72 Viral Load 72 #mg Tablets [002] 72 Liver Metastases 72 benzoic acid hyoscyamine sulfate 72 Fibromyalgia Pain 72 Venous Thromboembolism 72 Immunomedics Announces 72 Transdermal Delivery 72 Serious Infections 72 alfa 2a 72 SPRYCEL ® 72 Drug Prevents 72 Mycophenolate Mofetil 72 Prodrug 72 Advanced Pancreatic Cancer 72 Tyrosine Kinase Inhibitor 72 Nitazoxanide 72 R Saizen R 72 Adjuvant Therapy 72 Clinical Efficacy 72 Zoledronic Acid 72 Dasatinib 72 Endovascular Treatment 72 Relapsing Remitting Multiple Sclerosis 72 Methylprednisolone 72 Antipsychotic 72 Oral Spray 72 Allergic Rhinitis 72 Intravitreal 72 Formoterol 72 Fluorouracil 72 Proton Pump Inhibitors 72 Live Attenuated 72 Inhaled Insulin 72 Aliskiren 72 See WARNINGS 72 Eszopiclone 72 Decitabine 72 Sinus Infections 72 PEGINTRON TM 72 Prove Effective 72 HDAC Inhibitor 72 Hip Fractures 72 Enoxaparin 72 Telaprevir VX 72 Intrathecal 72 First Patient Treated 72 Bazedoxifene 72 Skeletal Muscle 72 Million Milestone Payment 72 Interferon Gamma 72 Release Tablets 72 Lanthanum Carbonate 72 Bivalirudin 72 Treat Anemia 72 Calcium Supplements 72 Less Invasive 72 Dose Escalation Study 72 Vildagliptin 72 R brand levalbuterol 72 Ranolazine 71 FDA Approves Generic 71 Randomized Phase 71 VIVITROL ® 71 Hydrochloride 71 Receives Fast Track 71 HCl Injection 71 Gastric Ulcers 71 Testosterone Patch 71 Bone Metastases 71 Successfully Treated 71 Randomized Study 71 Inhibits 71 Vaccine Candidate 71 Experimental Vaccine 71 Moxifloxacin 71 Lubiprostone 71 Cilostazol 71 Antidepressant Drug 71 Randomized Double blind 71 Cutaneous T 71 Subcutaneous 71 Tesamorelin 71 Inhalation Solution 71 Cholesterol Levels 71 Spectrum Pharmaceuticals Announces 71 Paraplatin ® 71 Randomized Clinical Trial 71 Transdermal System 71 Low Doses 71 Bare Metal Stents 71 Calcium Vitamin D 71 Pain Relievers 71 Advanced Ovarian Cancer 71 Pregnancy Linked 71 Post Operative 71 Confirms Efficacy 71 FDA Clearance 71 Reduces Mortality 71 Demonstrates Statistically Significant 71 Osteoarthritis Pain 71 Cervical Cancer Vaccine 71 Blood Clots 71 Gets FDA Clearance 71 Randomized Trials 71 Files Investigational 71 Oral Contraceptive 71 Genes Linked 71 Capecitabine 71 Weight Loss Drug 71 Antigen Specific 71 HER2 Positive Breast Cancer 71 Ethinyl Estradiol 71 hydrochloride tablets 71 Stent Placement 71 Potent Antiviral Activity 71 Budesonide 71 Myelodysplastic Syndromes 71 Heartburn Drugs 71 Test Detects 71 Gastric Cancer 71 FDA Warns 71 Protease Inhibitors 71 Commonly Used 71 REPRONEX ® menotropins 71 Induces 71 Mouse Model 71 NICE Recommends 71 Improve Outcomes 71 Topical Cream 71 HCV Genotype 71 PEGylated anti 71 Allergic Reactions 71 Chemotherapy Regimen 71 inhalation aerosol 71 Delayed Release 71 Toremifene 71 LENALIDOMIDE 71 ergot derivatives 71 Cardiovascular Disease Risk 71 Antipsychotic Drugs 71 Intravenous Formulation 71 Angiotensin Converting Enzyme 71 Intravenous Immunoglobulin 71 Liver Injury 71 Clinical Outcome 71 Nilotinib 71 Diabetic Nephropathy 71 Capsules CII 71 Orthostatic Hypotension 71 Brain Metastases 71 Palonosetron 71 Begins Dosing 71 STELARA TM 71 Non Invasive Treatment 71 Nasal Powder 71 Elagolix 71 Fluconazole 71 TO AVOID PREGNANCY WHILE 71 Pharmacokinetics PK 71 Atypical Antipsychotics 71 Cinacalcet 71 Colorectal Cancer Risk 71 Anticancer Drug 71 Newly Diagnosed 71 Receives SFDA Approval 71 Ovarian Cancer Patients 71 Stress Incontinence 71 Pafuramidine 71 Clostridium difficile Infection 71 IN PATIENTS WITH 71 Genes Predict 71 Lower Blood Pressure 71 Replacement Therapy 71 Placebo Controlled Study 71 Menopausal Symptoms 71 Oral Cladribine 71 Immunotherapeutic 71 pralatrexate injection folate analogue 71 Hematological Cancers 71 ODT metoclopramide HCl PEPCID 71 Alpha interferons including 71 Shows Statistically Significant 71 Commence Phase 71 J Am Coll 71 Erectile Dysfunction Drug 71 Vascular Grafts 71 Methylnaltrexone 71 Stomach Cancer 71 Insulin Glargine 71 mg Tablets 71 Cell Transplants 71 Study Shows Benefits 71 Interferon beta 1a 71 Liposomal 71 Immunogenicity 71 Guidelines Issued 71 dependent kinase inhibitor 71 Breast Tumors 71 Receives Orphan Drug 71 #mg #mg [001] 71 Lipid Lowering 71 Pegloticase 71 Seasonal Flu Vaccine 71 Hydrochloride Injection 71 Paclitaxel Carboplatin 71 Recommends Approval 71 Vitamin D Linked 71 Dose Finding 71 Montelukast 71 ANDA Filing 71 Node Positive 71 5 Fluorouracil 71 Treatment Naive 71 Soriatane R 71 Bronchodilator 71 dual endothelin receptor antagonist 71 ® lenalidomide 71 Conjugate 71 capsules USP 71 Subgroup Analysis 71 Placebo Controlled 71 NMDA Receptor 71 Prolongs Life 71 Treprostinil 71 Virus Infection 71 Phase Ib Clinical Trial 71 ALVESCO ® 71 Evoclin R 71 Sumatriptan Succinate 71 Hypercholesterolemia 71 Bare Metal Stent 71 XOPENEX R 70 R lenalidomide 70 Ovitrelle R Serostim 70 Saquinavir 70 Osteoarthritis Patients 70 Recurrent Breast Cancer 70 Tegretol carbamazepine 70 Antidepressant Use 70 Sagent Pharmaceuticals Announces 70 Diuretic 70 Pegylated Liposomal Doxorubicin 70 Bone Marrow Cells 70 Prophylaxis 70 DIURIL R 70 Vaccine Protects Against 70 Study Casts Doubt 70 Itraconazole 70 Ziprasidone 70 Study Reinforces 70 5 HT3 antagonist 70 sapropterin dihydrochloride 70 SABER ™ 70 ORENCIA ® 70 Hormone Therapy 70 Protein Linked 70 Soriatane 70 Million Doses 70 Inflammatory Arthritis 70 Taro Receives 70 Receptor Antagonists 70 Thrombotic 70 Chemoradiation 70 Sustained Efficacy 70 Epratuzumab 70 Long Lasting 70 Diabetic Foot Ulcer 70 Molecular Diagnostic Test 70 Orally Disintegrating Tablets 70 Castration Resistant Prostate Cancer 70 Combination Clinical Trial 70 Nasal Spray 70 Chronic Myeloid Leukemia 70 Unresectable 70 Preterm Labor 70 Atypical Antipsychotic 70 Atopic Dermatitis 70 Integrase Inhibitor 70 Inflammatory Disease 70 R famotidine 70 Peginterferon alfa 2a 70 TRANSDUR ® 70 Interferon Alpha 70 Ozarelix 70 TRANSDUR ™ 70 R bisoprolol Euthyrox 70 Small Molecule 70 Non Inferiority 70 Medication Errors 70 Tolerability 70 phenyl salicylate methylene blue 70 Contaminant Found 70 Xeloda ® 70 IMiDs ® 70 Abdominal Pain 70 ARIXTRA R 70 Presents Preclinical 70 Increased Risk 70 Blood Pressure Drugs 70 Sandostatin R 70 Heart Stents 70 Acute Ischemic Stroke 70 Cyclophosphamide 70 Novel Mechanism 70 Primary Hypercholesterolemia 70 Localized Prostate Cancer 70 BUPHENYL ® sodium phenylbutyrate 70 Betaferon R 70 Begin Clinical Trials 70 Metabolic Disorder 70 Prevent Breast Cancer 70 Preclinical Study 70 Soft Tissue Sarcoma 70 Seasonal Allergic Rhinitis 70 Collaborators Present 70 Topical Gel 70 Hepatocellular Carcinoma 70 Influenza Virus Vaccine 70 Contrast Agent 70 balsalazide disodium Capsules 70 #mg #mg #mg [003] 70 Randomized Phase II 70 nizatidine 70 Adenoviral 70 Therapeutic Vaccine 70 Antibiotic Treatment 70 Hemoglobin Levels 70 Valproic Acid 70 Hepatitis B Virus 70 Taxane 70 Malignant Glioma 70 Pneumonia Vaccine 70 Acute Migraine 70 Treating Heart Failure 70 Clinically Tested 70 Significant Reduction 70 Pandemic Influenza Vaccine 70 R roscovitine CDK cyclin 70 Inactivated 70 Milestone Payment From 70 Malaria Vaccine 70 PEGylated Fab fragment 70 Bicalutamide 70 Conjugate Vaccine 70 Recurrent Ovarian Cancer 70 Eases Pain 70 Resubmission 70 Prognostic Significance 70 Patient Enrolment 70 5MG TAB 70 Kidney Transplant Recipients 70 Postherpetic Neuralgia 70 Human Monoclonal Antibody 70 Lupus Nephritis 70 lexidronam injection 70 Uric Acid 70 Eur J 70 Pharmacodynamics 70 Atypical Hemolytic Uremic Syndrome 70 ribavirin USP 70 Immune Cells 70 Radical Prostatectomy 70 Cold Sores 70 Vicriviroc 70 Capsules USP 70 Intravesical 70 Agonist MABA program 70 Asthma COPD 70 ST Elevation Myocardial 70 Oral Suspension Oral Suspension 70 Invasive Breast Cancer 70 Sanofi Pasteur Fluzone 70 Platelet Inhibition 70 Breast Cancer Patients 70 Carbidopa Levodopa 70 CDC Recommends 70 Improves Quality 70 Treatment Shows Promise 70 Hepatitis C Treatment 70 vinorelbine tartrate 70 Diabetic Foot Ulcers 70 R metformin Concor 70 CYP#A# substrate 70 Clinical Trial Enrollment 70 Regimens 70 Acute Heart Failure 70 Testosterone Levels 70 Drug Maker 70 Multidrug 70 Clinical Evaluation 70 Acute Attacks 70 Wafer polifeprosan 70 Reveals Positive 70 Levofloxacin 70 Orally administered 70 Aloprim TM allopurinol sodium 70 Initiates Phase 2b 70 Seasonal Allergies 70 Febuxostat 70 Cancer Treatments 70 Skin Lesions 70 Gene Linked 70 Avian Flu Vaccine 70 Initiates Dosing 70 Blood Glucose Testing 70 Topline Results 70 Minimally Invasive Treatment 70 Antidepressants Linked 70 ORLive Presents 70 Divalproex Sodium 70 Injection Site 70 Receive Milestone Payment 70 arsenic trioxide injection 70 Lowering Blood Pressure 70 Metastatic Renal Cell Carcinoma 70 Potentially Deadly 70 Decongestant 70 Lansoprazole 70 Ebola Vaccine 70 Bone Fractures 70 1mg 2mg 70 Levoleucovorin 69 Submits Supplemental 69 Allogeneic 69 Thiazolidinediones 69 Adjunctive 69 Drug Coated Stent 69 Helps Prevent 69 Eluting Stent 69 Daptomycin 69 Corticosteroid 69 Polyethylene Glycol 69 Demonstrates Superior 69 Prostate Tumors 69 #MG TAB * 69 Obesity Linked 69 Weight Loss Pill 69 Presents Positive Preclinical 69 Valopicitabine 69 Meta Analysis 69 Telithromycin 69 Phase IIa Trial 69 Patent Covering 69 Chemotherapeutic Agents 69 Advisers Urge 69 Gene Variation 69 Bacterial Infection 69 Bone Mineral Density 69 Glucose Control 69 Novel Method 69 Anthracycline 69 Stent Implantation 69 Indomethacin 69 Anticancer Drugs 69 Certolizumab 69 Renal Function 69 alpha 2a 69 Late Breaker 69 Tuberculosis Vaccine 69 Ischemic Stroke 69 MRSA Infections 69 Dry Powder Inhalers 69 Signaling Pathway 69 Randomized Double Blind Placebo 69 Peginterferon alfa 2b 69 Clindamycin 69 Treatment Naïve Patients 69 Novartis Trileptal 69 PROCTOCORT ® Suppository Hydrocortisone 69 Influenza Vaccine Production 69 OSMOPREP TM 69 Asthma Symptoms 69 Blood Clotting 69 Gene Variants 69 Lamotrigine 69 Supplemental Biologics License Application 69 Zovirax acyclovir 69 Recall Issued 69 Cancer Cells 69 SinoFresh TM 69 COLAZAL ® 69 Cognitive Impairment 69 cromolyn sodium 69 Hydrochlorothiazide 69 Chronic Renal Failure 69 Blood Pressure Medication 69 Sleep Disturbances 69 Novel Therapeutic 69 Eltrombopag 69 Colorectal Adenomas 69 Nanoemulsion 69 Crixivan 69 Cardiovascular Outcomes 69 ® chorionic gonadotropin 69 Aerosolized 69 FDA Approval 69 Gum Disease 69 Antibiotic Resistant 69 Drug Eluting 69 Significant Reductions 69 Prostate Biopsy 69 Subtypes 69 Excretion 69 Pramlintide 69 Vaccine Adjuvants 69 Brain Atrophy 69 Chemotherapy Induced 69 RNAi Therapeutic 69 Lipid Levels 69 Vitro Activity 69 Lowers Cholesterol 69 Adenoma 69 Significant Improvements 69 Transplant Patients 69 R brand arformoterol 69 Stent Restenosis 69 Adjuvanted 69 Levaquin levofloxacin 69 NAVISTAR R 69 metformin HCl 69 Interferon Alfa 69 Liver Tumors 69 Cervical Dystonia 69 Didanosine 69 Sangamo BioSciences Announces 69 C1 Inhibitor 69 BioSante Pharmaceuticals Announces 69 Desloratadine 69 ketoconazole USP Gel 69 tazobactam 69 interferon beta 1a infertility 69 Extended Release Tablets 69 Antibiotic Use 69 Gene Mutation 69 ibuprofen Injection 69 Monopril 69 pan histone deacetylase 69 Adefovir 69 Hydralazine 69 tretinoin #.# 69 #mg BID [003] 69 Chronic Inflammation 69 Prevent Stroke 69 Preclinical Models 69 Drug Eluting Coronary Stent 69 Oral Anticoagulant 69 Lung Cancers 69 Chronic Constipation 69 Sublingual 69 Dendritic Cells 69 Follicular Lymphoma 69 #/#mg 69 TNF Blockers 69 RNAi Therapeutics 69 Achieves Unprecedented 69 Miconazole 69 Antipsychotic Drug 69 STERIS Corporation Announces 69 Myocardial Ischemia 69 potent CYP#A# inhibitors 69 Total Knee Arthroplasty 69 Milestone Payments 69 investigational oral inhibitor 69 SPL# Gel vaginal microbicide 69 platform HDL Mimetic 69 Smooth Muscle

Back to home page